Biolase Inc Expected To Post A Loss Of 4 Cents A Share: Earnings Preview

November 26

11/08/2021 24:37

* BIOLASE Inc  BIOL.OQ   BIOL.O  is expected to show a rise in
quarterly revenue when it reports results on August 12. 
* The Irvine, California-based company is expected to report   a
182.7% increase in revenue to $8.306 million from $2.94 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for BIOLASE Inc is for a
loss of 4 cents per share. For the same quarter last year, the
company reported a loss of 12 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for BIOLASE Inc is
$2​, about 70.5% above​ its last closing price of $0.59. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.05       -0.05      -0.06     Missed  -20
 Dec. 31 2020  -0.04       -0.04      -0.07     Missed  -90.9
 Sep. 30 2020  -0.05       -0.05      -0.05     Met     6.2​
 Jun. 30 2020  -0.17       -0.17      -0.12     Beat    29.4
 Mar.          -0.14​      -0.17      -0.11     Beat    34​
 31​ 2020​                                              
 Dec. 31 2019              -0.05      -0.05     Met     0​
 Sep. 30 2019  -0.16       -0.14      -0.12     Beat    12.2
 Jun. 30 2019  -0.12       -0.12      -0.13     Missed  -5.4
 This summary was machine generated August 10 at 23:37 GMT.  All
figures in US dollars unless otherwise stated